| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Molly M Huntsman | |
| Scott M Paluszkiewicz | |||
| Brandon S Martin | |||
| P2860 | cites work | Neuroligins and neurexins link synaptic function to cognitive disease | Q22251092 |
| Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis | Q24323108 | ||
| Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome | Q24530286 | ||
| Altered synaptic plasticity in a mouse model of fragile X mental retardation | Q24530695 | ||
| Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function | Q24608468 | ||
| Driving fast-spiking cells induces gamma rhythm and controls sensory responses | Q24627041 | ||
| Neurophysiological and Computational Principles of Cortical Rhythms in Cognition | Q24630528 | ||
| Neurosteroids: endogenous role in the human brain and therapeutic potentials | Q24632113 | ||
| Advances in the treatment of fragile X syndrome | Q24632814 | ||
| Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits | Q24657867 | ||
| Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors | Q24673026 | ||
| Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2 | Q26269865 | ||
| Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2 | Q26269913 | ||
| Common circuit defect of excitatory-inhibitory balance in mouse models of autism | Q26269924 | ||
| Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons | Q26269926 | ||
| Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome | Q27303466 | ||
| Immunolocalization of mGluR1alpha in specific populations of local circuit neurons in the cerebral cortex | Q28140990 | ||
| From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome | Q28247567 | ||
| Neurosteroids: endogenous regulators of the GABA(A) receptor | Q28256904 | ||
| Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin | Q28258590 | ||
| Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome | Q28273791 | ||
| The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation | Q28296169 | ||
| Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes | Q28303541 | ||
| Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression | Q28564770 | ||
| Cl- uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1 | Q28566006 | ||
| Control of excitatory and inhibitory synapse formation by neuroligins | Q28568459 | ||
| Neonatal development of the rat visual cortex: synaptic function of GABAA receptor alpha subunits | Q28574932 | ||
| Neuroligin 2 is exclusively localized to inhibitory synapses | Q28576687 | ||
| Developmentally-programmed FMRP expression in oligodendrocytes: a potential role of FMRP in regulating translation in oligodendroglia progenitors | Q28580499 | ||
| Independent assembly and subcellular targeting of GABA(A)-receptor subtypes demonstrated in mouse hippocampal and olfactory neurons in vivo | Q28586363 | ||
| The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits | Q28588310 | ||
| Interneurons of the neocortical inhibitory system | Q29547509 | ||
| Model of autism: increased ratio of excitation/inhibition in key neural systems | Q29547530 | ||
| Cortical inhibitory neurons and schizophrenia | Q29547683 | ||
| Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes | Q29616326 | ||
| Postnatal Neurodevelopmental Disorders: Meeting at the Synapse? | Q29616332 | ||
| Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function | Q29616372 | ||
| Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome | Q29616495 | ||
| Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP). | Q37411441 | ||
| The developmental integration of cortical interneurons into a functional network | Q37475593 | ||
| Amygdala inhibitory circuits and the control of fear memory | Q37531107 | ||
| Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability | Q37616726 | ||
| GABAB receptor coupling to G-proteins and ion channels | Q37775207 | ||
| The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation | Q38317052 | ||
| Expression of FMR1, FXR1, and FXR2 genes in human prenatal tissues | Q38321701 | ||
| Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome | Q38501407 | ||
| Open-label riluzole in fragile X syndrome | Q39819390 | ||
| Molecular mechanisms of interaction between the neuroprotective substance riluzole and GABA(A)-receptors | Q39985079 | ||
| GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex | Q40097657 | ||
| Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. | Q40151344 | ||
| A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system | Q40929779 | ||
| Fragile-X syndrome: a particular epileptogenic EEG pattern | Q41433374 | ||
| Temporal modulation of GABA(A) receptor subunit gene expression in developing monkey cerebral cortex | Q41676923 | ||
| Highly specific neuron loss preserves lateral inhibitory circuits in the dentate gyrus of kainate-induced epileptic rats | Q41697748 | ||
| GABA(A) receptor-mediated miniature postsynaptic currents and alpha-subunit expression in developing cortical neurons | Q41708997 | ||
| Nucleus-specific differences in GABA(A)-receptor-mediated inhibition are enhanced during thalamic development | Q41714103 | ||
| Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice. | Q41844282 | ||
| Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities | Q42042937 | ||
| Sorting of striatal and cortical interneurons regulated by semaphorin-neuropilin interactions | Q42508121 | ||
| Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein | Q42875155 | ||
| Early developmental alterations in GABAergic protein expression in fragile X knockout mice | Q43063055 | ||
| Origins of epilepsy in fragile X syndrome | Q43067748 | ||
| Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome | Q43237114 | ||
| Diverse types of interneurons generate thalamus-evoked feedforward inhibition in the mouse barrel cortex. | Q43578195 | ||
| GABA(A) receptor alpha1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. | Q43581695 | ||
| GABA(B) receptors mediate motility signals for migrating embryonic cortical cells | Q43679920 | ||
| Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor | Q43838084 | ||
| Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. | Q43892381 | ||
| Cell type- and input-specific differences in the number and subtypes of synaptic GABA(A) receptors in the hippocampus. | Q43940149 | ||
| Early sequential formation of functional GABA(A) and glutamatergic synapses on CA1 interneurons of the rat foetal hippocampus | Q44095430 | ||
| Evidence that Sema3A and Sema3F regulate the migration of GABAergic neurons in the developing neocortex | Q44231704 | ||
| Blockade of GABA(B) receptors alters the tangential migration of cortical neurons. | Q44539346 | ||
| GABAA receptor maturation in relation to eye opening in the rat visual cortex | Q44762478 | ||
| The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development | Q44767968 | ||
| Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice | Q44843160 | ||
| Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA A receptor alpha5 subunit-deficient mice. | Q44986641 | ||
| Role of class 3 semaphorins in the development and maturation of the septohippocampal pathway. | Q45073794 | ||
| Experience and activity-dependent maturation of perisomatic GABAergic innervation in primary visual cortex during a postnatal critical period. | Q45127985 | ||
| Time-matched pre- and postsynaptic changes of GABAergic synaptic transmission in the developing mouse superior colliculus | Q45231919 | ||
| Slow kinetics of miniature IPSCs during early postnatal development in granule cells of the dentate gyrus. | Q45974379 | ||
| Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures | Q46058214 | ||
| Developmental expression of GABA(A) receptor subunit and GAD genes in mouse somatosensory barrel cortex | Q46081132 | ||
| Taurine improves congestive functions in a mouse model of fragile X syndrome | Q46111209 | ||
| Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS). | Q46205774 | ||
| Selective resistance of taurine-fed mice to isoniazide-potentiated seizures: in vivo functional test for the activity of glutamic acid decarboxylase. | Q46410783 | ||
| Developmental profile of GABAA-mediated synaptic transmission in pyramidal cells of the somatosensory cortex | Q46437563 | ||
| A noncanonical release of GABA and glutamate modulates neuronal migration. | Q46486119 | ||
| Disruption of postsynaptic GABA receptor clusters leads to decreased GABAergic innervation of pyramidal neurons | Q46527450 | ||
| Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. | Q46626541 | ||
| Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. | Q46681406 | ||
| Defined types of cortical interneurone structure space and spike timing in the hippocampus | Q35946394 | ||
| Modulation of neocortical interneurons: extrinsic influences and exercises in self-control | Q36247696 | ||
| Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. | Q36562979 | ||
| Fragile X syndrome and autism at the intersection of genetic and neural networks | Q36603922 | ||
| Neuroanatomy of fragile X syndrome: the temporal lobe | Q36734713 | ||
| Switch in the expression of rat GABAA-receptor subtypes during postnatal development: an immunohistochemical study | Q36739893 | ||
| Gephyrin clustering is required for the stability of GABAergic synapses | Q36766163 | ||
| Refining the roles of GABAergic signaling during neural circuit formation | Q36859347 | ||
| Pyramidal cells of the rat basolateral amygdala: synaptology and innervation by parvalbumin-immunoreactive interneurons | Q36924433 | ||
| Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice | Q36926795 | ||
| Advances in behavioral genetics: mouse models of autism | Q36937876 | ||
| Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome | Q36978553 | ||
| Activation of GABAA receptors: views from outside the synaptic cleft. | Q37022454 | ||
| Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome | Q37059491 | ||
| Frontostriatal deficits in fragile X syndrome: relation to FMR1 gene expression | Q37074462 | ||
| Multiple modes of network homeostasis in visual cortical layer 2/3. | Q37127176 | ||
| Social approach in genetically engineered mouse lines relevant to autism | Q37138180 | ||
| Differential metabotropic glutamate receptor expression and modulation in two neocortical inhibitory networks | Q37190458 | ||
| GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation | Q37198498 | ||
| Axonal GABAA receptors. | Q37240087 | ||
| Differential synaptic localization of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal pyramidal cells | Q37275701 | ||
| Defining the role of GABA in cortical development. | Q37372212 | ||
| Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond. | Q37383902 | ||
| Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model | Q46731641 | ||
| Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. | Q46889350 | ||
| Expression of distinct alpha subunits of GABAA receptor regulates inhibitory synaptic strength | Q47717822 | ||
| Riluzole, a novel antiglutamate, blocks GABA uptake by striatal synaptosomes | Q48123517 | ||
| Epilepsy and EEG findings in males with fragile X syndrome. | Q48135370 | ||
| Fronto-striatal dysfunction and potential compensatory mechanisms in male adolescents with fragile X syndrome | Q48201398 | ||
| Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain | Q48275073 | ||
| Two dynamically distinct inhibitory networks in layer 4 of the neocortex | Q48276407 | ||
| Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome | Q48337615 | ||
| Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome | Q48351859 | ||
| Postsynaptic targets of somatostatin-containing interneurons in the rat basolateral amygdala | Q48362067 | ||
| RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice | Q48392342 | ||
| Decreased expression of the GABAA receptor in fragile X syndrome | Q48394848 | ||
| Potentiation of cortical inhibition by visual deprivation. | Q48438986 | ||
| Developmental changes in KCC1, KCC2, and NKCC1 mRNA expressions in the rat brain. | Q48455129 | ||
| Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. | Q48461687 | ||
| Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia. | Q48472265 | ||
| Early postnatal plasticity in neocortex of Fmr1 knockout mice. | Q48478142 | ||
| Inhibitory synaptogenesis in mouse somatosensory cortex. | Q48579158 | ||
| Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus. | Q48615671 | ||
| GABAergic cell subtypes and their synaptic connections in rat frontal cortex. | Q48632270 | ||
| Quantitative aspects of synaptogenesis in the rat barrel field cortex with special reference to GABA circuitry. | Q48914786 | ||
| Mice lacking the major adult GABAA receptor subtype have normal number of synapses, but retain juvenile IPSC kinetics until adulthood. | Q48975128 | ||
| Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. | Q51083891 | ||
| Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse. | Q51932364 | ||
| Epilepsy in fragile X syndrome. | Q51952378 | ||
| Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. | Q51985541 | ||
| Depolarizing GABAergic conductances regulate the balance of excitation to inhibition in the developing retinotectal circuit in vivo. | Q52018171 | ||
| Neurodevelopmental effects of the FMR-1 full mutation in humans. | Q52019051 | ||
| A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort | Q57544660 | ||
| Two networks of electrically coupled inhibitory neurons in neocortex | Q57860911 | ||
| A network of fast-spiking cells in the neocortex connected by electrical synapses | Q59090645 | ||
| The Establishment of GABAergic and Glutamatergic Synapses on CA1 Pyramidal Neurons is Sequential and Correlates with the Development of the Apical Dendrite | Q63433206 | ||
| Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis | Q73206517 | ||
| Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse | Q74060519 | ||
| GABA receptor antagonists modulate postmitotic cell migration in slice cultures of embryonic rat cortex | Q74303565 | ||
| Salient features of synaptic organisation in the cerebral cortex | Q74746755 | ||
| The fragile X syndrome | Q74809876 | ||
| Autism spectrum disorder in Fragile X syndrome: differential contribution of adaptive socialization and social withdrawal | Q80103577 | ||
| Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors | Q29616809 | ||
| Excitatory actions of gaba during development: the nature of the nurture | Q29617435 | ||
| Parvalbumin neurons and gamma rhythms enhance cortical circuit performance | Q29619163 | ||
| Long-term sensory deprivation selectively rearranges functional inhibitory circuits in mouse barrel cortex. | Q30488660 | ||
| Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome | Q30496828 | ||
| Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy. | Q31793881 | ||
| Input-dependent synaptic targeting of alpha(2)-subunit-containing GABA(A) receptors in synapses of hippocampal pyramidal cells of the rat. | Q31900249 | ||
| Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. | Q32063419 | ||
| Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila | Q33323032 | ||
| An anatomical substrate for experience-dependent plasticity of the rat barrel field cortex | Q33727555 | ||
| Differential modulation of proliferation in the neocortical ventricular and subventricular zones | Q33911054 | ||
| Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome | Q33953276 | ||
| Characterization of vigabatrin‐associated optic atrophy | Q33972736 | ||
| The emotional brain, fear, and the amygdala | Q33972788 | ||
| Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome | Q34003224 | ||
| Neurosteroids and epilepsy | Q34099166 | ||
| Endocannabinoid signaling in the brain | Q34125520 | ||
| Seizures in fragile X syndrome: characteristics and comorbid diagnoses | Q34143566 | ||
| Subunit composition, distribution and function of GABA(A) receptor subtypes | Q34143787 | ||
| Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. | Q34157712 | ||
| The role of GABA in the pathophysiology and treatment of anxiety disorders. | Q34319322 | ||
| Pharmacological characterization of GABAA receptors in taurine-fed mice. | Q34364433 | ||
| Neuro-endocrine basis for altered plasma glucose homeostasis in the Fragile X mouse | Q34364470 | ||
| GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis | Q34400922 | ||
| RNA targets of the fragile X protein. | Q34456641 | ||
| GABA-based therapeutic approaches: GABAA receptor subtype functions | Q34479365 | ||
| The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes | Q34481002 | ||
| MeCP2 dysfunction in Rett syndrome and related disorders | Q34519177 | ||
| Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. | Q34660995 | ||
| Differential response of cortical plate and ventricular zone cells to GABA as a migration stimulus. | Q34750391 | ||
| Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knock-out mice. | Q34778657 | ||
| Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. | Q35143354 | ||
| Tonically active GABA A receptors: modulating gain and maintaining the tone. | Q35757312 | ||
| Molecular structure and physiological functions of GABA(B) receptors | Q35842984 | ||
| Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. | Q35844502 | ||
| P433 | issue | 5 | |
| P921 | main subject | fragile X syndrome | Q221472 |
| P304 | page(s) | 349-364 | |
| P577 | publication date | 2011-09-21 | |
| P1433 | published in | Developmental Neuroscience | Q15763713 |
| P1476 | title | Fragile X syndrome: the GABAergic system and circuit dysfunction | |
| P478 | volume | 33 |
| Q90263694 | A Conserved Tyrosine Residue in Slitrk3 Carboxyl-Terminus Is Critical for GABAergic Synapse Development |
| Q38161847 | A blueprint for research on Shankopathies: a view from research on autism spectrum disorder |
| Q26781265 | Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder |
| Q64996589 | Altered cortical Cytoarchitecture in the Fmr1 knockout mouse. |
| Q28076224 | An Evolutionarily Conserved Mechanism for Activity-Dependent Visual Circuit Development |
| Q35824354 | Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography-What Can be Interpreted from the Available Information? |
| Q38770206 | Autism spectrum disorder in the scope of tactile processing. |
| Q36252621 | Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission. |
| Q60914551 | Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective |
| Q28086869 | Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders |
| Q24613296 | Conceptualizing neurodevelopmental disorders through a mechanistic understanding of fragile X syndrome and Williams syndrome |
| Q35092766 | Cortical abnormalities and non-spatial learning deficits in a mouse model of CranioFrontoNasal syndrome. |
| Q92825070 | Cyfip1 Haploinsufficiency Does Not Alter GABAA Receptor δ-Subunit Expression and Tonic Inhibition in Dentate Gyrus PV+ Interneurons and Granule Cells |
| Q98944961 | Decreased reproducibility and abnormal experience-dependent plasticity of network dynamics in Fragile X circuits |
| Q45011378 | Decreased surface expression of the δ subunit of the GABAA receptor contributes to reduced tonic inhibition in dentate granule cells in a mouse model of fragile X syndrome |
| Q34006575 | Deficient tonic GABAergic conductance and synaptic balance in the fragile X syndrome amygdala |
| Q47595806 | Delayed Maturation of Fast-Spiking Interneurons Is Rectified by Activation of the TrkB Receptor in the Mouse Model of Fragile X Syndrome. |
| Q46628249 | Delayed in vitro development of Up states but normal network plasticity in Fragile X circuits |
| Q50574417 | Developmental expression of the neuroligins and neurexins in fragile X mice. |
| Q99206499 | Developmental onset of enduring long-term potentiation in mouse hippocampus |
| Q36517246 | Developmental regulation of spatio-temporal patterns of cortical circuit activation |
| Q38101157 | Diffuse traumatic brain injury and the sensory brain. |
| Q36970472 | Distinct Defects in Synaptic Differentiation of Neocortical Neurons in Response to Prenatal Valproate Exposure. |
| Q38147860 | Drug discovery for autism spectrum disorder: challenges and opportunities |
| Q89063900 | Dysregulation and restoration of homeostatic network plasticity in fragile X syndrome mice |
| Q64056860 | Enriched Environments as a Potential Treatment for Developmental Disorders: A Critical Assessment |
| Q37687700 | EphA7 signaling guides cortical dendritic development and spine maturation |
| Q38607739 | Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics |
| Q30540852 | Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis |
| Q33766106 | Fragile X Syndrome: Prevalence, Treatment, and Prevention in China |
| Q30376771 | Fragile X mental retardation protein knockdown in the developing Xenopus tadpole optic tectum results in enhanced feedforward inhibition and behavioral deficits. |
| Q57828399 | Fragile X syndrome |
| Q50573783 | GABAB receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome. |
| Q38787519 | GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model |
| Q27013583 | GABAergic signaling as therapeutic target for autism spectrum disorders |
| Q37739172 | Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism |
| Q28506705 | Genetic evidence for the adhesion protein IgSF9/Dasm1 to regulate inhibitory synapse development independent of its intracellular domain |
| Q34349576 | Genetic insights into the functional elements of language |
| Q38189521 | Gephyrin: a master regulator of neuronal function? |
| Q92237673 | Group I mGluR-Mediated Activation of Martinotti Cells Inhibits Local Cortical Circuitry in Human Cortex |
| Q35142914 | Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid signaling and affects hyperexcitability in a mouse model of fragile X syndrome. |
| Q37564195 | Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models |
| Q34435526 | Increasing our understanding of human cognition through the study of Fragile X Syndrome |
| Q47835820 | Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders |
| Q28080022 | Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells |
| Q64120816 | Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders |
| Q37018574 | Moving Toward Integrative, Multidimensional Research in Modern Psychiatry: Lessons Learned From Fragile X Syndrome |
| Q27022529 | NINDS epilepsy and autism spectrum disorders workshop report |
| Q54375474 | Neuregulin 1-induced AKT and ERK phosphorylation in patients with fragile X syndrome (FXS) and intellectual disability associated with obstetric complications. |
| Q55155951 | Paradoxical effect of baclofen on social behavior in the fragile X syndrome mouse model. |
| Q36090455 | Pathological plasticity in fragile X syndrome |
| Q92308939 | Polysomnographic Findings in Fragile X Syndrome Children with EEG Abnormalities |
| Q35771116 | Psychosis and catatonia in fragile X: Case report and literature review |
| Q41258644 | Rescue of deficient amygdala tonic γ-aminobutyric acidergic currents in the Fmr-/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulator |
| Q47952892 | STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study |
| Q47605720 | Scn1a dysfunction alters behavior but not the effect of stress on seizure response. |
| Q27328413 | Sensory cortex underpinnings of traumatic brain injury deficits |
| Q37134260 | Sensory hypo-excitability in a rat model of fetal development in Fragile X Syndrome |
| Q90677669 | Sleep, brain development, and autism spectrum disorders: Insights from animal models |
| Q27023257 | Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes |
| Q30385019 | The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome. |
| Q36813950 | The basolateral amygdala γ-aminobutyric acidergic system in health and disease |
| Q26998540 | The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome |
| Q50344880 | The developmental switch in GABA polarity is delayed in fragile X mice. |
| Q90696674 | The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling |
| Q53667436 | The roles of motor activity and environmental enrichment in intellectual disability. |
| Q51306660 | The tenth annual amygdala, stress, and PTSD conference: "The amygdala: Dysfunction, hyperfunction, and connectivity". |
| Q35741409 | Tlx3 promotes glutamatergic neuronal subtype specification through direct interactions with the chromatin modifier CBP. |
| Q50304062 | Translational medicine: Mice and men show the way. |
| Q55503150 | Visual subcircuit-specific dysfunction and input-specific mispatterning in the superior colliculus of fragile X mice. |
| Q64074462 | Widespread Alterations in Translation Elongation in the Brain of Juvenile Fmr1 Knockout Mice |
Search more.